Results

Total Results: 923 records

Showing results for "patient safety indicators".
Users also searched for: quality indicators

441. Arthritis and Nontraumatic Joint Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-13121.pdf
     December 05, 2013 - A patient may choose to receive more than one injection over time. … its approval, without following good manufacturing practice, and without proving the treatment’s safety … stating that MSC therapy is investigational because of insufficient evidence or insufficient long-term safety … such as a hospital blood bank or blood processing laboratory) according to standard blood-processing safety … Health care delivery infrastructure and patient management: Because patients with OA already have the

442. 08 Functional Limitations Potential High Impact 2012-12-10 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/08_functional_limitations_potential_high_impact_2012-12-10.pdf
     January 01, 2012 - Use of the system would represent a way to purportedly enhance patient mobility and allow patients … of dimethyl fumarate because of the efficacy and safety profile reported in patients with RRMS. … Experts remained divided on per-patient costs with OBI-1 therapy, but thought clinicians and patients … Regarding potential acceptance by patients and clinicians, one clinical expert commented, “The safety … One research expert opined that elderly patients may have more reservations than a younger patient

443. Ced-Topic-Refinement (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ced-topic-refinement.pdf
     November 01, 2022 - FDA) makes decisions about the approval for marketing of products based on demonstrations of their safety … Patient- important outcomes may or may not be patient-reported (e.g., death). I. … For studies that involve researching the safety and effectiveness of new drugs and biological products … For studies that involve researching the safety and effectiveness of new drugs and biological products … "patient access schemes"[All Fields] 8.

444. Stroke-Atrial-Fibrillation Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/stroke-atrial-fibrillation_executive.pdf
     August 01, 2013 - The number of patients included in studies ranged from fewer than 100 to 170,291, with overlap in patient … The number of patients included in studies ranged from fewer than 600 to 170,291, with overlap in patient … Warfarin Ischemic stroke 1 (707) SOE = Low 9 LAA patients (1.3 events per 100 patient-years) and 6 … warfarin patients (1.6 events per 100 patient-years) had ischemic stroke, demonstrating no difference … Given variability in patient populations, concomitant therapies, and underlying patient care, cross-trial

445. White Paper: Narratively Describing Effects of Interventions in Systematic Reviews (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/white-paper-roadmap-interventions.pdf
     November 01, 2020 - The information in this report is intended to help healthcare decision makers—patients and clinicians … information, i.e., in the context of available resources and circumstances presented by individual patients … Direction of effect Serious adverse events Rate Ratio: 1.10 (95% CI, 0.70 to 1.71) Low SOE In patients … Pharmacologic and Nonpharmacologic Therapies in Adult Patients With Exacerbation of COPD: A Systematic … Comparative effectiveness and safety of cognitive behavioral therapy and pharmacotherapy for childhood

446. Management of suspected opioid overdose with Naloxone by Emergency Medical Services personnel (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/emt-naloxon_research-protocol.pdf
     November 29, 2016 - the comparative benefit and harms of titration of naloxone administered by EMS personnel until the patient … resumes sufficient spontaneous respiratory effort versus until the patient regains consciousness? … arrest, function, quality of life, other clinical sequelae of opioid overdose; healthcare utilization indicators … Review of naloxone safety for opioid overdose: practical considerations for new technology and expanded … National Highway Traffic Safety Administration. The National EMS Scope of Practice Model.

447. Biomarkers for Assessing and Managing Iron Deficiency Anemia in Late-Stage Chronic Kidney Disease: Future Research Needs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-kidney-disease-anemia_research.pdf
     January 01, 2013 - A New Taxonomy for Stakeholder Engagement in Patient-Centered Outcomes Research. … • No study performed analyses by patient subgroups. … We contacted the National Kidney Foundation Patient and Family Council to invite CKD patient/patient … In addition to diagnostic accuracy and safety, stakeholder discussion of the topic included additional … A new taxonomy for stakeholder engagement in patient-centered outcomes research.

448. Case Study Comparing Bayesian and Frequentist Approaches for Multiple Treatment Comparisons (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/indirect-comparisons_research.pdf
     March 01, 2013 - Efficacy and cardiac safety of propiverine in elderly patients - a double- blind, placebo-controlled … Efficacy and safety of tolterodine in patients with detrusor instability: a dose-ranging study. … Efficacy and safety of solifenacin succinate in Korean patients with overactive bladder: a randomised … Efficacy and cardiac safety of propiverine in elderly patients - a double- blind, placebo-controlled … Efficacy and safety of tolterodine in patients with detrusor instability: a dose-ranging study.

449. mHealth for Diabetes (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/tnd-0855-170515.pdf
     April 28, 2017 - A recent study found that patient ratings of mobile health applications are poor indications of those … and are available on patients’ mobile devices. … A recent study found that patient ratings of mobile health applications are poor indicators of those … Telehealth: Mapping the Evidence for Patient Outcomes From Systematic Reviews. … Developing a Framework for Evaluating the Patient Engagement, Quality, and Safety of Mobile Health Applications

450. mHealth for Diabetes (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0855-170515.pdf
     April 28, 2017 - A recent study found that patient ratings of mobile health applications are poor indications of those … and are available on patients’ mobile devices. … A recent study found that patient ratings of mobile health applications are poor indicators of those … Telehealth: Mapping the Evidence for Patient Outcomes From Systematic Reviews. … Developing a Framework for Evaluating the Patient Engagement, Quality, and Safety of Mobile Health Applications

451. Disposition of Comments: Technical Brief 37 Prevention, Diagnosis, and Management of Opioids, Opioid Misuse, and Opioid Use Disorder in Older Adults (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/tech-brief-37-opiod-use-adults-comments.pdf
     November 03, 2020 - , an educational pamphlet for patients, provision of patient information and pain management training … This alarm system can create a true safety net for elderly patients, with will decrease anxiety and … General Comments Research Is Needed to Increase Safety and Provide Effective Pain Management in Older … COPD) o cardiac disease o neurological disease We agree that more research is needed to increase safety … Masimo stands ready to work with you as you address these important patient safety issues for older

452. 13-MDM347013 30..38 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/outcomes-testing-evaluation_research.pdf
     January 01, 2009 - Additional patient outcomes and pathways in evaluations of testing. … No differences in health indicators were found at 1 year among patients who self-monitored compared … One of the most obvious pathways between testing and patients’ health runs through patient adherence … Prenatal screening and diagnosis of congenital toxoplasmosis: a review of safety issues and psychological … Full range of effects of testing on patient outcome

453. 13-MDM347013 30..38 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/whitepaper4-bossuyt02262010-2.pdf
     January 01, 2009 - Additional patient outcomes and pathways in evaluations of testing. … No differences in health indicators were found at 1 year among patients who self-monitored compared … One of the most obvious pathways between testing and patients’ health runs through patient adherence … Prenatal screening and diagnosis of congenital toxoplasmosis: a review of safety issues and psychological … Full range of effects of testing on patient outcome

454. Weight-Gain-Prevention Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/weight-gain-prevention_executive.pdf
     January 01, 2020 - inclusive enrollment criteria.19,20 Scope and Key Questions We aimed to compare the effectiveness, safety … For the intermediate outcomes, safety, clinical, and quality of life outcomes, we only abstracted data … Studies of overweight and obese patients were included if the study did not describe the goal of the … Health Indicators Warehouse. … Healthy Weight in Adults. www. healthindicators.gov/Indicators/ Healthyweightinadults_1207/ Profile/Data

455. labor-dystocia-protocol-amended-160728 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/labor-dystocia_research-protocol.pdf
     July 28, 2016 - balance between harms and benefits for both mother and baby that is considered acceptable to most patients … We will link studies to avoid duplication of patient cohorts. … The safety outcomes will be framed to help identify adverse events, including those from drug therapies … methodological quality of individual studies, study type, the characteristics of the comparator, and patients … Key Informants Key Informants are the end users of research, including patients and caregivers, practicing

456. Arthritis-Psoriatric Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/arthritis-psoriatric_executive.pdf
     April 01, 2012 - Finally, very little is known about the benefits or risks of these drugs in different patient subgroups … KQ 2: For patients with PsA, do drug therapies differ in their ability to improve patient-reported symptoms … KQ 3: For patients with PsA, do drug therapies differ in harms, tolerability, patient adherence, or … eligibility (inclusion and exclusion) criteria were designed with respect to study design or duration, patient … Safety and efficacy of adalimumab in treatment of patients with psoriatic arthritis who had failed

457. Identification and Treatment of Post-Acute Coronary Syndrome (ACS) Depression: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/acs-depression-research-protocol-amended.pdf
     February 15, 2017 - an acute ACS event • Settings: o Primary, specialty, inpatient KQ 2: What are the comparative safety … The safety outcomes will be framed to help identify adverse events, including those from drug therapies … Cardiology Patient Page. … Aripiprazole5 Yes, as an adjunct with an antidepressant FDA safety alert: uncontrollable urges to … care"[mesh] OR "Delivery of Health Care, Integrated"[Mesh] OR "Patient Care Team"[Mesh] OR "Patient

458. Arthritis and Nontraumatic Joint Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/01_-arthritis_potential_high_impact_june_2012.pdf
     January 01, 2012 - These safety concerns may present barriers to approval or barriers to diffusion if approved. … determinations stated MSC therapy is investigational because of insufficient evidence or long-term safety … Both groups had similar safety profiles. 29 In a study of patients with knee OA (Outerbridge grades … as a hospital blood bank or blood processing laboratory) according to standard blood processing safety … These safety concerns may present significant barriers to approval and diffusion if approved.

459. Disposition of Comments CER 194 Intermittent Inhaled Corticosteroids and Long-Acting Muscarinic Antagonists for Asthma (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-194-disposition-comments-inhaled-corticosteroids.pdf
     March 19, 2018 - What if they didn’t result in patient receiving systemic corticosteroids? … The combination of BUD/Form is not approved for children under 12 but efficacy and safety studies discussed … Ensure homogeneity of patient populations included in meta-analyses. … However, there is heterogeneity in the patient populations enrolled in these trials, in relation to … Tonya Winders, Asthma & Allergy Network We are not sure of this report's potential impact in patient

460. Breast-Biopsy-Update Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-biopsy-update_executive.pdf
     September 01, 2014 - on test performance and safety is not clear. … provide additional information allowing the exploration of heterogeneity for test performance and safety … Of note, studies often do not provide information on the risk of cancer among included patients. … patients were biopsied with vacuum-assistance and others were not) but the study did not report the … selection criteria, patient or lesion characteristics, adverse events, or patient-relevant outcomes